Functional results after mesorectal excision for rectal cancer: comparative study among surgical approaches.


Journal

Minerva surgery
ISSN: 2724-5438
Titre abrégé: Minerva Surg
Pays: Italy
ID NLM: 101777295

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 18 2 2022
medline: 23 7 2022
entrez: 17 2 2022
Statut: ppublish

Résumé

We analyzed the evolution of genitourinary dysfunctions in patients undergoing surgical treatment for rectal cancer, and compared open surgery, laparoscopy, robotic and TaTME. Functional outcomes were evaluate using standardized questionnaires, compiled at the start of treatment, after the end of Radiotherapy, at 1 and 6 months after surgery. In 72 patients 37.5% had low, 27.8% middle, and 34.7% high rectal cancers. Open technique was performed in 25% of cases, while 29.2% underwent laparoscopy, 20.8% TaTME and 25% robotic. We noted a deterioration in urogenital function: surgical technique can influence the result both in urinary and male sexual function but not ejaculation. Robotics and laparoscopy bring better outcomes than open surgery and TaTME. Female sexuality worsening seems not influenced by the technique. In general age, stage, complications, and anastomotic leakage appear to be predictive factors for functional dysfunctions. As reported in literature rectal cancer treatment leads to urogenital worsening: this seems to be progressive in male sexuality only, while female one and urinary function show a slight improvement in the first months, although a full recovery possibility is discussed. Is also reported how robotic and laparoscopy have a lower functional impact. TaTME has gained consensus thank to the excellent oncological and function outcomes, but in our study leads to worse results. Mini-invasive techniques guarantee the same oncological result than more invasive ones, but with better functional outcomes and tolerability; robotic surgery seems to be slight superior to laparoscopy, but with longer operative time.

Sections du résumé

BACKGROUND BACKGROUND
We analyzed the evolution of genitourinary dysfunctions in patients undergoing surgical treatment for rectal cancer, and compared open surgery, laparoscopy, robotic and TaTME.
METHODS METHODS
Functional outcomes were evaluate using standardized questionnaires, compiled at the start of treatment, after the end of Radiotherapy, at 1 and 6 months after surgery.
RESULTS RESULTS
In 72 patients 37.5% had low, 27.8% middle, and 34.7% high rectal cancers. Open technique was performed in 25% of cases, while 29.2% underwent laparoscopy, 20.8% TaTME and 25% robotic. We noted a deterioration in urogenital function: surgical technique can influence the result both in urinary and male sexual function but not ejaculation. Robotics and laparoscopy bring better outcomes than open surgery and TaTME. Female sexuality worsening seems not influenced by the technique. In general age, stage, complications, and anastomotic leakage appear to be predictive factors for functional dysfunctions. As reported in literature rectal cancer treatment leads to urogenital worsening: this seems to be progressive in male sexuality only, while female one and urinary function show a slight improvement in the first months, although a full recovery possibility is discussed. Is also reported how robotic and laparoscopy have a lower functional impact. TaTME has gained consensus thank to the excellent oncological and function outcomes, but in our study leads to worse results.
CONCLUSIONS CONCLUSIONS
Mini-invasive techniques guarantee the same oncological result than more invasive ones, but with better functional outcomes and tolerability; robotic surgery seems to be slight superior to laparoscopy, but with longer operative time.

Identifiants

pubmed: 35175013
pii: S2724-5691.22.08803-7
doi: 10.23736/S2724-5691.22.08803-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

318-326

Auteurs

Gianfrancesco Intini (G)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy - gianfrancesco.intini@gmail.com.

Simone M Tierno (SM)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Massimo Farina (M)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Marco M Lirici (MM)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Giorgio Lucandri (G)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Giuseppe Mezzetti (G)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Vito Pende (V)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Graziano Pernazza (G)

Unit of General and Robotic Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Francesco Stipa (F)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Carlo E Vitelli (CE)

Unit of General and Oncological Surgery, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH